Back
Clinuvel Pharmaceuticals Ltd. 10K Form
Sell
38
CLVLY
Clinuvel Pharmaceuticals Ltd.
Last Price:
$8.15
Seasonality Move:
1.87%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive CLVLY News And Ratings
See the #1 stock for the next 7 days that we like better than CLVLY
CLVLY Financial Statistics
Sales & Book Value
| Annual Sales: | $61.5M |
|---|---|
| Cash Flow: | $0 |
| Price / Cash Flow: | 15.85 |
| Annual Sales: | $2.70 |
| Price / Book: | 2.88 |
Profitability
| EPS (TTM): | 0.46550 |
|---|---|
| Net Income (TTM): | $23.3M |
| Gross Margin: | $40.5M |
| Return on Equity: | 19.45% |
| Return on Assets: | 17.14% |
Clinuvel Pharmaceuticals Ltd. Earnings Forecast
Key Clinuvel Pharmaceuticals Ltd. Financial Ratios
-
The Gross Profit Margin over the past 25 years for CLVLY is 65.78%.
-
The Selling, General & Administrative Expenses for CLVLY have been equal to 14.51% of Gross Profit Margin.
-
The Research & Development expenses have been 7.79% of Revenue.
-
The Interest Expense is 0.11% of Operating Income.
-
The Net Earning history of CLVLY is 38.07% of Total Revenues.
-
Per Share Earnings over the last 26 years have been positive in 15 years.
Clinuvel Pharmaceuticals Ltd. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | OTCM |
|---|---|
| Industry: | Biotechnology |
| Sector: | Health Care |
| Current Symbol: | CLVLY |
| Website: | clinuvel.com |
Debt
| Debt-to-Equity Ratio: | 0 |
|---|---|
| Current Ratio: | 17.37 |
| Quick Ratio: | 16.37 |
Price-to-Earnings
| Trailing P/E Ratio: | 17.52 |
|---|---|
| Forward P/E Ratio: | 0 |
CLVLY Technical Analysis vs Fundamental Analysis
Sell
38
Clinuvel Pharmaceuticals Ltd. (CLVLY)
is a Sell
Is Clinuvel Pharmaceuticals Ltd. a Buy or a Sell?
-
Clinuvel Pharmaceuticals Ltd. stock is rated a SellThe current Clinuvel Pharmaceuticals Ltd. [CLVLY] share price is $8.15. The Score for CLVLY is 38, which is 24% below its historic median score of 50, and infers higher risk than normal.